Why the study?
Does alloxan protect against experimental atherosclerosis through mechanisms independent of the pancreas in cholesterol-fed rabbits?
Does alloxan protect against experimental atherosclerosis through mechanisms independent of the pancreas in cholesterol-fed rabbits?
The protective effect of alloxan against experimental atherosclerosis in rabbits is mediated through its diabetogenic action on the pancreas, rather than direct effects on other tissues.
Answers are grounded in this paper and cite their sources.
Confirms pancreatic mediation of alloxan protection in this rabbit model; leaves open translation to other species or clinical atherosclerosis.
Experiments were performed to compare the effects of cholesterol feeding in (a) control rabbits, (b) alloxan-diabetic rabbits, and (c) rabbits injected with alloxan while the pancreas was temporarily occluded from the circulation. The alloxan-diabetic rabbits consumed significantly higher quantities of cholesterol and food and had serum cholesterol and lipoprotein (S(f) 5-9 and S(f) 16-30) concentrations significantly increased over the control levels. They failed to show a commensurate increase in the degree of atherosclerosis. Rabbits in which the diabetogenic action of alloxan was prevented by temporary occlusion of the pancreas from the circulation during its administration developed grades of hypercholesterolemia, hyperlipoproteinemia, and atherosclerosis not significantly different from the controls. The results are interpreted as indicating that the effects of alloxan on tissues other than the pancreas do not protect against experimental atherosclerosis produced by cholesterol feeding.
No takes yet. Share an insight, caveat, or question.
Cook et al. (1954) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: